Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01837654
Other study ID # 76/12
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2012
Est. completion date August 2012

Study information

Verified date November 2018
Source Assaf-Harofeh Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to find out whether plantarflexion has an effect on the degree of urinary urgency and on the amplitude of detrusor contraction during filling cystometry in patients with detrusor overactivity (DO).


Description:

Patients with urodynamic DO will be included in this study. During urodynamics, the mean peak detrusor pressures of each contraction will be documented and compared. At the beginning of the 2nd or 3rd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor. Following each wave, patients will be asked to grade the severity of the urgency by a visual analogue scale


Recruitment information / eligibility

Status Completed
Enrollment 22
Est. completion date August 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

All patients with urodynamic detrusor overactivity

Exclusion Criteria:

Inability to perform plantarflexion due to mental or physical disability

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Plantarflexion 2nd wave
At the beginning of the 2nd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor.
Plantarflexion - 3rd wave
At the beginning of the 3rd wave, patients will be asked to perform continuous plantar-flexion by pushing their tiptoes against the floor.

Locations

Country Name City State
Israel Assaf Harofe Medical Center Be'er Ya'aqov

Sponsors (1)

Lead Sponsor Collaborator
Assaf-Harofeh Medical Center

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean Peak Detrusor Pressures Mean peak detrusor pressures of each contraction through test completion, an average of 10 minutes
Secondary Severity of the Urgency by a 0-10 Visual Analogue Scale (VAS). Following each wave, patients will be asked to grade the severity of the urgency by a 0 (minimum) to 10 (maximum) visual analogue scale (VAS). through test completion, an average of 10 minutes
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05977634 - Transcutaneous Tibial Nerve Stimulation for Idiopathic Overactive Bladder N/A
Completed NCT02657057 - Effects of Transcutaneous and Percutaneous PTNS on Idiopathic OAB N/A
Completed NCT01192568 - Safety and Efficacy Evaluation of Oxybutynin Topical Gel In Children With Neurogenic Bladder Phase 4
Recruiting NCT05895045 - Yoga for Treatment of Overactive Bladder in Pediatric Patients N/A
Completed NCT03451175 - Reproductibility of Cystometry in Multiple Sclerosis Patient N/A
Terminated NCT03080389 - Sensitivity of Extended Cultures in Diagnosing Urinary Tract Infections
Completed NCT01629433 - Onabotulinumtoxina Intradetrusorial Injections and NGF Expression Phase 4
Completed NCT01781117 - Prognostic Value of the Urinary Nerve Growth Factor in the Patients With Benign Prostatic Hyperplasia N/A
Terminated NCT00845338 - Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor Overactivity Phase 2
Completed NCT03388086 - Efficacy of Two Onabotulinum Toxin Doses
Completed NCT04197466 - Comparison of Different Treatments for Overactive Bladder Syndrome N/A
Not yet recruiting NCT02009540 - Botulinum Toxin in the Treatment of Idiopathic Detrusor Overactivity Phase 4
Completed NCT04270526 - Minimizing Pain During Office Intradetrussor Botox Injection Phase 4
Enrolling by invitation NCT06212661 - Migraine Medication Effects on Urinary Symptoms
Completed NCT01408771 - "Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver N/A